Stock ATRI ATRION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Atrion Corporation

Equities

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
395 USD -0.99% Intraday chart for Atrion Corporation -1.82% +4.28%
Apr. 09 Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board CI
Feb. 29 Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,373 1,394 1,175 1,269 991.7 666.6
Enterprise Value (EV) 1 1,305 1,326 1,133 1,208 966.5 660.6
P/E ratio 40.2 x 38.1 x 36.8 x 38.8 x 28.6 x 34.4 x
Yield 0.69% 0.77% 1.03% 1.05% 1.47% 2.3%
Capitalization / Revenue 9.01 x 8.99 x 7.96 x 7.69 x 5.4 x 3.94 x
EV / Revenue 8.56 x 8.55 x 7.68 x 7.32 x 5.27 x 3.9 x
EV / EBITDA 25.7 x 25.8 x 23.9 x 24.7 x 18.1 x 17.5 x
EV / FCF 82.9 x 156 x 129 x 71.2 x -140 x -54.4 x
FCF Yield 1.21% 0.64% 0.78% 1.4% -0.71% -1.84%
Price to Book 6.52 x 5.86 x 4.88 x 5.2 x 4.11 x 2.74 x
Nbr of stocks (in thousands) 1,853 1,855 1,829 1,801 1,773 1,760
Reference price 2 741.1 751.5 642.2 704.9 559.4 378.8
Announcement Date 2/26/19 3/2/20 3/1/21 2/25/22 2/27/23 2/29/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 152.4 155.1 147.6 165 183.5 169.3
EBITDA 1 50.83 51.38 47.32 48.93 53.5 37.68
EBIT 1 41.71 40.53 35.67 36.04 39.69 22.58
Operating Margin 27.36% 26.14% 24.17% 21.84% 21.63% 13.33%
Earnings before Tax (EBT) 1 42.04 43.17 38.47 38.43 40.62 22.38
Net income 1 34.26 36.76 32.12 33.06 35.01 19.41
Net margin 22.47% 23.71% 21.76% 20.03% 19.08% 11.46%
EPS 2 18.44 19.73 17.44 18.18 19.56 11.02
Free Cash Flow 1 15.74 8.479 8.814 16.97 -6.904 -12.14
FCF margin 10.33% 5.47% 5.97% 10.28% -3.76% -7.17%
FCF Conversion (EBITDA) 30.97% 16.5% 18.63% 34.68% - -
FCF Conversion (Net income) 45.95% 23.06% 27.44% 51.33% - -
Dividend per Share 2 5.100 5.800 6.600 7.400 8.200 8.700
Announcement Date 2/26/19 3/2/20 3/1/21 2/25/22 2/27/23 2/29/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 68.4 68.2 41.4 61.2 25.2 6.02
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 15.7 8.48 8.81 17 -6.9 -12.1
ROE (net income / shareholders' equity) 17.3% 16.4% 13.4% 13.6% 14.5% 8.05%
ROA (Net income/ Total Assets) 12% 10.3% 8.43% 8.43% 9.33% 5.37%
Assets 1 285.8 357.9 381 391.9 375.4 361.4
Book Value Per Share 2 114.0 128.0 132.0 136.0 136.0 138.0
Cash Flow per Share 2 31.70 24.30 12.30 17.90 2.690 2.030
Capex 1 17.5 20.4 21.9 15.8 33.7 22.3
Capex / Sales 11.48% 13.19% 14.83% 9.59% 18.38% 13.18%
Announcement Date 2/26/19 3/2/20 3/1/21 2/25/22 2/27/23 2/29/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ATRION CORPORATION Stock Atrion Corporation
+4.28% 695M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ATRI Stock
  4. Financials Atrion Corporation